EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Targeting immune microenvironment–mediated mesenchymal transition in glioblastoma: Molecular mechanisms and translational strategies

Fengye Liu iD, Junyi Chen, Muying Yu, Yanlin Liu, Wencan Wang, Yi Pei, Shuyan Yang, Wenjing Yu

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology Advances, online erschienen am 22.03.2026. Verfasst von Fengye Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Southwest Medical University, Luzhou, Sichuan, China. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sichuan Natural Science Foundation, Sichuan Provincial Department of Education for the Provincial Undergraduate Innovation and Entrepreneurship Training Program of Southwest Medical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma remains uniformly lethal due to profound phenotypic plasticity and adaptive resistance. The proneural-to-mesenchymal transition (PMT) has emerged as a central axis functionally linking immune evasion, metabolic rewiring, and lineage remodeling. Relevant studies tend to interrogate the tumor microenvironment in a cell-type-specific manner, whereas accumulating evidence shows that PMT is not imposed by single populations but results from coordinated inputs of macrophages, T cells, neutrophils, astrocytes, and stromal partners through polarization dynamics, cytokine circuits (IL-6, TGF-β, IL-10), and metabolic modules (eg the lactate-HIF1a axis). Therapeutic strategies that distort this PMT-permissive ecosystem, including macrophage reprogramming (GM-CSF, CSF-1R blockade), immune checkpoint inhibition, metabolic targeting, and epigenetic modulation, have shown preliminary signals yet are constrained by redundancy, spatial heterogeneity, and compensatory feedback. This review reframes the immune microenvironment as a multicellular PMT-enforcing network, synthesizes cross-cell-type mechanistic evidence, and appraises translational attempts through the lens of PMT enforcement, while outlining opportunities such as biomarker-aligned stratification, spatial multi-omics guidance, and rational combinations designed to intercept PMT circuits. Anchoring therapeutic innovation in immune-driven PMT may provide a tractable entry to overcome resistance in glioblastoma.

Autor:innen und Institutionen

  • Clinical Medical College, Southwest Medical University, Luzhou, Sichuan, China.

ORCID-Profile: Fengye Liu

Förderung

  • Sichuan Natural Science Foundation
  • Sichuan Provincial Department of Education for the Provincial Undergraduate Innovation and Entrepreneurship Training Program of Southwest Medical University

Zitieren

APA

Liu, F., Chen, J., Yu, M., Liu, Y., Wang, W., Pei, Y., Yang, S., & Yu, W. (2026). Targeting immune microenvironment–mediated mesenchymal transition in glioblastoma: Molecular mechanisms and translational strategies. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag075

Vancouver

Liu F, Chen J, Yu M, Liu Y, Wang W, Pei Y, et al. Targeting immune microenvironment–mediated mesenchymal transition in glioblastoma: Molecular mechanisms and translational strategies. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag075

BibTeX
@article{Liu2026,
  author = {Liu, Fengye and Chen, Junyi and Yu, Muying and Liu, Yanlin and Wang, Wencan and Pei, Yi and Yang, Shuyan and Yu, Wenjing},
  title = {Targeting immune microenvironment–mediated mesenchymal transition in glioblastoma: Molecular mechanisms and translational strategies},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag075}
}
Kostenlos starten →